Zhuang Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zhuang Luo has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Jianwu Zhang
School of Pharmacy, North Sichuan Medical College
1 shared publicationRui Zhang
The Seventh People’s Hospital of Chengdu
1 shared publication- Shaoqing Shi
Department of Clinical Research Center, First Affiliated Hospital of Kunming Medical University, Kunming, China
1 shared publication Wei Luo
The People’s Hospital of Leshan
1 shared publication
Latest Publications
- 10 November 2018
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 25 (2) , 443-446
WWP2 Is One Promising Novel Oncogene
WWP2 is an E3 ubiquitin ligase and plays an important role in regulation of many cellular biological activities through ubiquitination and degradation of its substrates. Recently accumulating evidences indicate that WWP2 plays a crucial part in the pathogenesis in different types of tumors. In this report, the role of this gene especially in tumorigenesis was reviewed. WWP2 is dysregulated in various of tumors, and it promotes carcinogenesis mainly through PTEN/Akt signaling pathway. WWP2 also participates in anti-cancer agents’ sensitivity, indicating WWP2 may be a novel target for cancer treatment. WWP2 is one promising novel oncogene.
- 10 November 2018
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 25 (2) , 443-446
WWP2 Is One Promising Novel Oncogene
WWP2 is an E3 ubiquitin ligase and plays an important role in regulation of many cellular biological activities through ubiquitination and degradation of its substrates. Recently accumulating evidences indicate that WWP2 plays a crucial part in the pathogenesis in different types of tumors. In this report, the role of this gene especially in tumorigenesis was reviewed. WWP2 is dysregulated in various of tumors, and it promotes carcinogenesis mainly through PTEN/Akt signaling pathway. WWP2 also participates in anti-cancer agents’ sensitivity, indicating WWP2 may be a novel target for cancer treatment. WWP2 is one promising novel oncogene.